Table 5 Correlation of S100A3 mRNA expression with clinicalpathological parameters in patients with gastric carcinoma.

Gender

Male

61

11

34

9

8

0.17

Female

19

3

5

8

2

Age (y)

<65

54

10

31

6

7

0.08

>65

26

4

8

11

3

Tumor differentiation

Well¹

3

0

0

1

2

0.22^a

Moderate²

33

8

7

12

6

0.03^b

Poor³

44

6

32

4

2

0.01^c

Tumor size (cm)

<5.0

41

6

23

5

7

0.96

>5.0

39

8

16

12

3

Depth of wall invasion

Mucosa, submucosa¹

6

2

1

2

1

0.45^a

Muscularis propria²

18

6

8

4

0

0.33^b

Subserosa, serosa³

56

10

34

6

6

0.72^c

Stage

I + II

19

2

7

5

5

0.04

III + IV

61

12

32

12

5

Microscopic subtypes

Intestinal¹

57

10

29

11

7

0.87^a

Diffuse²

18

4

8

4

2

0.26^b

Atypical³

5

0

2

2

1

0.21^c

Lymph node metastasis

Yes

64

11

35

11

7

0.16

No

16

3

4

6

3